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Abstract 
Scope: To determine the contribution of intestinally and liver-derived lipoproteins to the 
postprandial plasma triacylglycerol (TAG) response in APOE3/E3 and E3/E4 individuals 
following chronic dietary fat manipulation. 
Methods and Results: In sequential order, participants (n=12 E3/E3, n=11 E3/E4) followed 
low fat (LF); high-fat, high-saturated fat (HSF); and HSF with 3.45 g/day docosahexaenoic 
acid (HSF-DHA) diets, each for 8 weeks. After each dietary period, an acute test meal with a 
macronutrient profile representative of the dietary intervention was consumed. 
Apolipoprotein (apo)B isoforms were determined in isolated TAG-rich lipoprotein fractions 
(Sf>400, Sf 60-400 and Sf 20-60) by specific ELISA. A genotype*meal/diet interaction for 
the Sf>400 fraction apoB-48 response (P<0.05) was observed, with higher concentrations 
reached after the LF than HSF-DHA meal in E4 carriers. This finding was associated with a 
lower TAG content of the Sf>400 particles. Fasting Sf 60-400 and 20-60 apoB-48 
concentrations were also significantly higher in E4 carriers. No impact of genotype on the 
apoB-100 responses was evident. 
Conclusion: Our study revealed marked effects of dietary fat composition on the Sf>400 
apoB-48 response and particle TAG content in E4 carriers relative to the ‘wild-type’ E3/E3 
genotype, which suggest APOE genotype is a potential modulator of chylomicron particle 
synthesis. 
  
1. Introduction 
The concentration of triacylglycerol (TAG) in the fasting and postprandial (fed) state has 
been consistently associated with cardiovascular disease (CVD) risk, although causality has 
not been fully established [1]. The contribution of the liver-derived TAG-rich lipoproteins 
(TRL), VLDL and their remnants, to the pathogenesis of atherosclerosis has been well 
described [2-4]. Elevated levels of chylomicrons and chylomicron remnants which circulate 
following a meal have also been directly and indirectly related to CVD risk. However, 
different mechanisms are thought to operate for the liver and intestinally-derived TRL [1]. 
Yet, insight into the atherogenicity of these intestinally-derived TRL have been slower to 
emerge due to methodological difficulties associated with the determination of their inherent 
apolipoprotein, apolipoprotein (apo)B-48, in plasma and TRL fractions [5].  
 The APOE (epsilon) genotype is considered to be an important genetic determinant of 
the inter-individual variation in postprandial lipid metabolism [6-8]. with higher TAG 
concentrations reported in E4 carriers relative to the ‘wild-type’ E3/E3 group [9]. However, 
little is known about the contribution of intestinally (apoB-48) and liver (apoB-100) derived 
TRL to the total TAG response according to APOE genotype. Of the studies conducted [10-
13], APOE genotyping has been performed retrospectively resulting in differences in age, 
male/female ratio and subject numbers between the E3/E3 and E3/E4 study groups, which 
makes the independent impact of genotype difficult to establish with certainty. Using a 
prospective genotyping approach in the SATgenε study, we aimed to determine for the first 
time, both the postprandial TRL apoB-48 and B-100 responses to meals of varying fat 
composition in E3/E3 and E3/E4 men, matched for age and BMI.  
 
2. Methods 
2.1 Subjects and postprandial protocol 
Details of the SATgenε dietary intervention [8] and postprandial study [9] have been 
published elsewhere. The study was given a favourable ethical opinion for conduct by the 
University of Reading Research Ethics committee (project 08/62) and is registered at 
Clinicaltrials.gov I.D NCT0138. All subjects gave informed consent prior to participation in 
the study. Briefly 23 men prospectively recruited according to APOE genotype (n=12 E3/E3 
and n=11 E3/E4) underwent a postprandial investigation at the end of the 8 week prescribed 
iso-energetic low fat (LF) diet, high fat, high saturated fat (HSF) diet and HSF diet with 3.45 
g/day of docosahexaenoic acid (HSF-DHA). The macronutrient composition of the diets and 
test meals are shown in Table 1. After an overnight fast, the subjects attended the clinical 
investigation unit where an indwelling cannula was inserted into a vein in the forearm, and a 
fasting blood sample (0 min) was taken. The test meal was given in the form of a warm 
chocolate drink containing the test oils with toast and jam, and consumed within 20 min. For 
isolation of the TRL fractions, Svedberg flotation rate (Sf)>400 (predominately 
chylomicrons), Sf 60-400 (large TAG-rich VLDL1) and Sf 20-60 (smaller TAG-poor 
VLDL2), blood was collected at 180, 240, 300, 360 and 480 min post meal.  
 
2.2 TRL isolation and apoB analysis 
Blood samples and TRL fractions were isolated as previously described [9]. ApoB-48 and B-
100 were measured in the TRL fractions using specific in-house ELISAs [14]. For the apoB-
100 ELISA, some modifications to the original method were made. Briefly, the ELISA plate 
was coated with 1 mg/ml of a 1:1 mixture of apoB-100 monoclonal antibodies 4G3 and 5E11 
(Ottawa Heart Institute Research Corporation, University of Ottawa) in 0.1 M bicarbonate-
carbonate buffer (pH 9.6) for 16 h at 4°C. After washing with 0.02 M PBS containing 0.05% 
(by volume) Tween 20 and 0.1% BSA (PBSBT), the plate was blocked with 150 μl of 0.02M 
PBS, 0.025% (by volume) Tween 20 and 3% BSA at 37°C for 1 h. A 9 point standard curve 
was prepared by serial dilution of LDL (density=1.019-1.063 g/ml, Source Bioscience, 
Nottinghamshire, UK) in PBSBT to produce a concentration range of apoB-100 from 1.25 
μg/ml to 5 ng/ml. The Sf>400 fraction was diluted 1:6, the Sf 60-400 fraction 1:1000 and Sf 
20-60 fraction 1:2000 in PBSBT prior to the addition to the plate. Standards, samples and 
quality controls (100 μl/well) were added in duplicate to the plate and incubated for 2 h at 
37°C. The plate was washed, 100 μl of goat anti-apoB antibody conjugated to horse radish 
peroxidase (Source Bioscience) was added to the plate at a final dilution of 1:20,000, and 
incubated for a further 2 h at 37°C. After washing the plate, 100 μl of 3, 3’, 5, 5’-
tetramethylbenzamidine substrate (Sigma, Dorset, UK) was added for 30 min and reaction 
stopped by the addition of 1M HCL. The absorbance was read at 450 nm. The inter-assay 
CVs for the apoB-48 and apoB-100 assays were less than 10%. 
 
2.3 Statistical analysis 
Details of the sample size calculation for the postprandial study have been previously 
described [9]. Data were analysed using PASW statistics 18 (SPSS Inc, Chicago, IL). All data 
were checked for normality and log transformed where necessary before statistical analysis. 
Repeated measures analysis of variance (ANOVA) determined the effects of the meals on the 
postprandial time course responses, with ‘meal’ and ‘time’ as the within-subject factors and 
‘genotype’ as the between-subjects factor. A one-within, one-between repeated measures 
ANOVA analysed differences in the fasting concentrations and postprandial summary 
measures between the genotype groups. For a significant main effect of ‘diet/meal’, Student’s 
paired t-tests were performed, with a Holm’s sequential Bonferroni correction applied to 
correct for significant pairwise differences. Data are presented as mean ± SEM. Values of P ≤ 
0.05 were taken as significant. 
 
3. Results 
3.1 ApoB-48 responses 
The impact of the test meals on the postprandial apoB-48 response in the Sf>400 fraction 
(predominately chylomicrons) was influenced by APOE genotype (meal*genotype 
interaction, P=0.030), with higher apoB-48 concentrations following the LF compared with 
the HSF-DHA meal in the E3/E4 group only (Fig.1). This was reflected in the greater AUC 
(44%), IAUC (53%) and maxC (53%) after the LF than HSF-DHA meal (P≤0.010; Table 2). 
ApoB-48 responses were not different between meals in the E3/E3 group (Fig. 1 and Table 
2). 
Since  meal*genotype interactions were not evident for the apoB-48 responses in the 
Sf 60-400 and Sf 20-60 TRL fractions, data for the two genotype groups within each TRL 
fraction were combined to determine the overall effects of the diet/meals on the fasting and 
postprandial responses. In the Sf 60-400 fraction, fasting apoB-48 concentrations were higher 
after the LF than HSF-DHA diet (P=0.006; Supplementary Table 1). A higher postprandial 
time course response, AUC, IAUC and maxC was also observed after the LF than HSF and 
HSF-DHA meals (P≤0.017; Supplementary Fig.1 and Supplementary Table 1). Only the 
apoB-48 IAUC (found to be higher after the HSF compared with the LF meal) was 
influenced by meal composition in Sf 20-60 TRL fraction (P=0.005; Supplementary Table 1).  
Independent of the diet/meals, APOE genotype was shown to influence fasting apoB-
48 concentrations.  Compared with the wild-type E3/E3 group, E4 carriers had higher 
concentrations in both the Sf 60-400 (46.5 vs. 63.5 pmol/l; P=0.048) and Sf 20-60 (47.8 vs 
78.1 pmol/l; P=0.003) fractions. A genotype effect was also observed for maxC reached after 
the meals in the Sf 20-60 fraction, with on average higher apoB-48 concentrations in the 
E3/E4 (160 pmol/l) than E3/E3 (122 pmol/l) group (P=0.035). 
 
3.2 ApoB-100 responses 
Independent of genotype, diet/test meal composition only influenced fasting and postprandial 
apoB-100 concentrations in the Sf 60-400 TRL fraction (P<0.001; Supplementary Table 1). 
Fasting concentrations were 52% and 42% lower after the HSF-DHA than LF and HSF diets, 
respectively. The postprandial time response profile, AUC and maxC were also lower after 
HSF-DHA compared with the other test meals (P≤0.005; Supplementary Fig. 1 and 
Supplementary Table 1). There was no impact of diet/meal composition or genotype on 
fasting apoB-100 concentration or postprandial responses determined in the Sf>400 and Sf 
20-60 fractions. 
 
3.3 Sf>400 fraction TRL composition 
As each chylomicron particle has only one apoB-48 molecule, the TAG, cholesterol and apoE 
concentrations [9] were expressed as a ratio of the apoB-48 concentration in order to establish 
particle composition and gain insight into possible mechanisms underlying the differences in 
the Sf>400 fraction apoB-48 responses between the meals in the E4 carriers. There was a 
significant meal*genotype interaction for the TAG:apoB-48 ratio (an indicator of particle 
TAG content) of the Sf>400 particles after the meal (P=0.015), with a higher ratio observed 
after the HSF than LF meal in the E4 carriers only (P=0.009; Fig.2). The IAUC for the 
postprandial TAG:apoB-48 ratio was also lower after the LF meal than following the HSF 
and HSF-DHA meals (P≤0.023). Differences were not evident in the postprandial 
TAG:apoB-48 ratio between meals in the E3/E3 group. Meal composition and genotype did 
not influence the cholesterol:apoB-48 or apoE:apoB-48 ratios (data not shown). 
 
4. Discussion 
An APOE4 genotype (20-25% Caucasians) has been associated with reduced longevity [15] 
and increased CVD risk [16], with an impact on fasting and postprandial lipid metabolism 
likely to significantly contribute to the higher CVD incidence. Here, in the SATgenε study, 
we observed a greater responsiveness of the Sf>400 fraction apoB-48 response to diet/meals 
of varying fat content and composition in E4 carriers, with little impact of APOE genotype on 
TRL apoB-100 responses.  
Only three studies have determined postprandial TRL apoB-48 and apoB-100 
responses according to APOE genotype [10, 11, 13], but findings are inconsistent. In two 
studies [10, 11], similar fasting and postprandial TRL apoB-48:B-100 ratios and retinyl 
palmitate (RP, an indirect marker of chylomicrons and their remnants) concentrations were 
observed in response to high fat meals (100-105 g) in E3/E3 and E4 carriers. Using stable 
isotopes (a primed constant infusion of deuterated leucine) in the fed state, Welty et al. [13] 
reported E3/E4 individuals to have a significantly lower postprandial TRL (d<1.006 g/ml) 
apoB-100 production rate after small meals (each equivalent to 1/20th of their daily food 
intake) representative of an American diet (36% fat) whereas the TRL apoB-48 pool size and 
clearance of chylomicron remnants were not different between the genotype groups. In 
contrast to previous studies which genotyped retrospectively, we prospectively recruited 
according to APOE genotype and matched the groups for age and BMI, two important 
determinants of the postprandial lipaemic response [17, 18]. E4 carriers had higher fasting Sf 
60-400 and Sf 20-60 apoB-48 concentrations, and reached higher postprandial (maxC) 
concentrations in the Sf 20-60 fraction than E3/E3 individuals, with apoB-100 responses 
similar in the genotype groups. The technique used to measure intestinally-derived 
lipoproteins may provide an explanation for the inconsistent findings on the effects of APOE 
genotype on TRL apoB responses. Early studies [10, 11] included RP in the test meal to label 
the lipid moiety of chylomicrons and determined RP responses in plasma and TRL fractions. 
However, discordance in the data from studies comparing apoB-48 (the integral protein 
component of chylomicrons) with RP responses, has highlighted limitations of the latter as a 
specific marker of chylomicron remnants [19]. Furthermore, the isolation of only TAG-rich 
and TAG-poor TRL fractions in the earlier studies compared with the three distinct TRL 
fractions of progressively increasing density and decreasing particle size [20] in the current 
study, may have masked the specific effects of APOE genotype on TRL apoB-48 
metabolism. 
A novel aspect of our study design is the use of test meals which were representative 
of the fat content and composition of the intervention diet, providing a more physiological 
assessment of the effects of diets with varying fat composition on postprandial lipaemia. As 
far as the authors are aware, only one other study has determined the effects of habitual 
dietary fat manipulation on TRL apoB responses according to APOE genotype [12]. 
Following a high-fat PUFA-rich diet for 29 days, fasting concentrations of TRL apoB-48 and 
B-100 were similar in the E3/E3 and E3/E4 groups, with E4 carriers showing a delayed 
clearance of both apoB-48 and B-100 TRL remnants after the test meals, irrespective of 
whether they were enriched in SFA (PUFA/SFA ratio = 0.2) or PUFA (PUFA/SFA ratio = 
1.3). In the present study, greater postprandial changes in apoB-48, but not B-100 in response 
to the test meal fat content and composition were evident in E4 carriers. In particular, higher 
Sf>400 apoB-48 responses and IAUC after the LF than HSF-DHA meal are suggestive of 
either a greater production and/or impaired clearance of chylomicrons after the low fat, high 
carbohydrate test meal.  
Insulin plays a pivotal role in chylomicron metabolism by regulating apoB-48 
secretion, the activity of the hydrolytic enzyme lipoprotein lipase and the expression of 
hepatic remnant receptors [21, 22]. Acutely, insulin secretion has been shown to be 
influenced by test meal fat composition [23]. In the current study, as we have previously 
reported, the insulin and glucose responses to the meals were similar within each genotype 
group [9], indicating that differences in insulin action do not contribute to the marked effects 
of meal composition on apoB-48 responses in APOE4 carriers. Animal studies have reported 
gut hormones, in particular glucagon-like peptide 2 to play an important role in stimulating 
intestinal lipid absorption and chylomicron production [24-26] but findings in humans are 
limited [27]. The impact of APOE genotype on gut hormone production is currently 
unknown.  
Previous reports by ourselves [14] and others [28, 29] have suggested that the meal fat 
composition could influence the lipid and apolipoprotein content of TRL particles which has 
been proposed to affect their rate of metabolism in the circulation. A notable difference in the 
TAG content (TAG:apoB-48 ratio) of the postprandial Sf>400 TRLs after the meals was 
evident, with a lower TAG content and smaller incremental change in the TAG enrichment of 
the TRL particles after the LF relative to the high-fat meals. Since TRL particle size is 
determined primarily by the TAG content, the smaller chylomicrons circulating after the LF 
than HSF-DHA meal may have been more resistant to hydrolysis by lipoprotein lipase which 
could result in delayed clearance and provide an explanation for the greater Sf>400 fraction 
apoB-48 response relative to the HSF-DHA meal. Although the apoE content of the Sf>400 
particles was not different, the apoE isoform (E3 versus E4) present on the surface of the 
TRLs may have also influenced their metabolism in the circulation. In particular, apoE3 
shows a greater preference for smaller TAG-poor TRL whereas apoE4 binds specifically to 
larger TAG-rich particles [30, 31] and is associated with a more atherogenic lipoprotein 
profile [30]. We speculate that the larger TAG-rich chylomicrons circulating after the HSF-
DHA meal (than LF meal) were more enriched with apoE4, facilitating a more rapid 
conversion to smaller denser remnant particles than after the LF meal. However, similar Sf 
20-60 fraction apoB-48 responses (representing small chylomicrons and chylomicron 
remnants) were observed after the HSF-DHA and LF meals, which were lower relative to the 
HSF meal. It is unclear from our data whether differences in production rate and clearance of 
these particles from the circulation or rates of conversion between Sf>400 to Sf 60-400 and Sf 
20-60 fractions were responsible for these findings.      
With the increasing recognition of the contribution of raised levels of intestinally-
derived lipoproteins after a fat containing meal to CVD risk, there is considerable interest in 
the effects of diet on postprandial fat handling and TRL composition. Our study has revealed 
marked effects of the LF diet/meal on Sf>400 apoB-48 responses in E4 carriers relative to the 
HSF-DHA diet/meal, which was associated with a notable difference in the estimated TAG 
content of the chylomicron particles. Although the postprandial Sf>400 TAG time response 
profiles were comparable after the LF, HSF and HSF-DHA diet/meals, our findings indicate 
that consumption of the lower fat and higher carbohydrate diet may have impacted on 
pathways regulating chylomicron synthesis and particle lipid composition, particularly in 
APOE3/E4 individuals. Our novel findings are of interest and potentially lend support to a 
recent study in men classified with the metabolic syndrome [32] which proposed that the 
enterocyte does not just process dietary TAG but may also upregulate pathways for the 
synthesis of fatty acids (de novo lipogenesis) during higher intakes of carbohydrate. The 
APOE genotype now represents one of the few common genotypes consistently associated 
with longevity, chronic disease risk and responsiveness to dietary manipulation. Therefore, 
further studies, in particular kinetic studies using stable isotopes, are warranted to confirm 
our findings and provide insights into mechanisms underlying the effects of APOE genotype 
on intestinal fat absorption, chylomicron synthesis and metabolism. 
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FIGURE LEGENDS 
Figure 1: Mean ± SEM for the apoB-48 responses in the Svedberg flotation rate (Sf)>400 
fraction after consumption of test meals representative of the low fat diet (LF, open squares), 
high saturated fat diet (HSF, closed circles) and HSF diet with fish oil (HSF-DHA, open 
circles) in the APOE3/E3 (n = 12) and APOE3/E4 (n = 11) groups. For the E3/E4 group, 
there was a significant test meal (P=0.032) and time (P<0.001) effect, with a trend for a 
meal*time interaction (P=0.077). 
 
Figure 2: Mean ± SEM for the change in triacylglycerol (TAG) content of the Svedberg 
flotation rate (Sf)>400 fraction lipoproteins (presented as number of TAG molecules per 
apoB-48 particle) after consumption of test meals representative of the low fat diet (LF, open 
squares), high fat, high saturated fat diet (HSF, closed circles) and HSF diet with fish oil 
(HSF-DHA, open circles) in the APOE3/E3 (n = 12) and APOE3/E4 (n = 11) groups. For the 
E3/E4 group, there was a significant test meal (P=0.018) and time (P<0.001) effect. 
  
Table 1: Macronutrient composition of the diets and test meals 
Composition Diets†  Test meals 
 LF HSF HSF-DHA  LF HSF HSF-DHA 
%Energy from fat 24.0 38.0 38.0  27.5 37.8 37.8 
 SFA  8.0 18.0 18.0  8.3 18.0 18.3 
 MUFA 8.0 12.0 12.0  12.2 12.2 12.2 
 PUFA 6.0 6.0 6.0  6.4 6.4 6.6 
%Energy from CHO 55.0 45.0 45.0  55.0 45.0 45.1 
%Energy from protein 17.0 17.0 17.0  17.0 17.0 17.0 
†Target daily intake. Abbreviations: CHO, carbohydrate; HSF, high fat, high saturated fat 
diet; HSF-DHA, HSF diet with 3.45 g/day docosahexaenoic acid; LF, low fat; SFA, saturated 
fatty acid. 
  
Table 2: Postprandial summary measures for the Sf>400 fraction apoB-48 responses in 
the APOE3/E3 and APOE3/E4 groups 
 Test meals ANOVA 
 LF HSF HSF-DHA meal (P=) 
APOE3/E3 (n=12)     
   Fasting (pmol/l) 
   AUC 
   IAUC 
   maxC (pmol/l) 
15.2 ± 2.3 
22.1 ± 3.2 
14.8 ± 3.1 
95 ± 13 
13.5 ± 2.3 
22.8 ± 4.5 
16.3 ± 4.2 
104 ± 25 
16.5 ± 2.6 
25.0 ± 5.6 
17.0 ± 5.3 
107 ± 28.0 
0.815 
0.585 
0.857 
0.831 
APOE3/E4 (n=11)     
   Fasting (pmol/l) 
   AUC 
   IAUC 
   maxC (pmol/l) 
15.9 ± 2.3 
48.0 ± 10.6* 
40.4 ± 10.7* 
201 ± 50† 
15.7 ± 1.8 
28.9 ± 5.1 
21.4 ± 5.0 
117 ± 21 
15.8 ± 2.3 
26.6 ± 7.5 
19.0 ± 7.2 
95 ± 26 
0.954 
0.007 
0.034 
0.003 
Values represent mean ± SEM. Abbreviations: AUC, area under the curve; HSF, high fat, 
high saturated fat diet; HSF-DHA, HSF diet with 3.45 g/day docosahexaenoic acid; IAUC, 
incremental AUC; LF, low fat ; maxC, maximum concentration. AUC and IAUC are 
expressed as pmol/l x 480 min. 
*P≤0.01, compared with HSF-DHA meal, †P≤0.013, compared with HSF and HSF-DHA 
meals. 
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